Veterinary Vaccines Market
Veterinary Vaccines Market Size, Share & Trends Analysis Report, By Product (Livestock Vaccines, Companion Animal Vaccines, Porcine Vaccines, Equine Vaccines, Poultry Vaccines, Aquaculture Vaccines, and Others), By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, and Conjugate Vaccines), By Diseases (Poultry Diseases, Companion Animal Diseases, Livestock Diseases, Aquaculture Diseases, and Others), Forecast Period (2022-2028)
Veterinary vaccines market is anticipated to grow at a CAGR of 9.2% during the forecast period. The increasing outbreak of cattle diseases and growing demand for their treatment are some key factors driving the growth of the market. The rising incidence of zoonotic diseases, initiatives by various government agencies and animal associations to maintain animal health, and the rising demand for animal-derived food products are some other factors contributing to the market growth. According to the World Economic Forum (WEF), it was estimated that zoonoses are responsible for 2.5 billion cases of human illness and 2.7 million human deaths worldwide each year.
In June 2022, Union Minister of Agriculture & Farmers’ Welfare “Shri Narendra Singh Tomar” launched Animal Vaccine and other Diagnostic Kits developed by the ICAR-National Research Centre on Equines, Hisar, Haryana, India. The Ancovax Vaccine on Equines is an inactivated SARS-CoV-2 Delta (COVID-19) Vaccine for Animals. The immunity induced by Ancovax neutralizes both Delta and Omicron Variants of SARS-CoV-2. The Vaccine contains inactivated SARS-CoV-2 (Delta) antigen with Alhydrogel as an adjuvant. It is safe for dogs, lions, leopards, mice and rabbits.
Segmental Outlook
The global veterinary vaccines market is segmented by product, technology, and diseases. The market segmentation based on the product includes livestock vaccines, companion animal vaccines, porcine vaccines, equine vaccines, poultry vaccines, aquaculture vaccines and others. Based on technology, the market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, toxoid vaccines, recombinant vaccines, DNA vaccines, and conjugate vaccines. Based on diseases, the market is segmented into poultry diseases, companion animal diseases, livestock diseases, aquaculture diseases, and others.
Livestock Segment Holds Considerable Share in the Global Veterinary Vaccines Market
The rising livestock population, cohesive government initiatives, and the outbreak of diseases among cattle and sheep are some key factors driving the growth of this segment. Vaccinations that are developed for preventing E. coli include Aviguard and Nobilis E. coli inac by Merck & Co., Inc. According to Zoetis, the prevalence rate of E. Coli in various cattle categories ranges between 0.2% to 27.8%.
Regional Outlook
The global veterinary vaccines market is further segmented based on geography including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa and Latin America). The market can be analyzed for a particular region or country level as per the requirement. North America held a considerable share in the global veterinary vaccines market. The rising public-private funding and research grants for developing safe & effective veterinary vaccines and the growing number of clinical trials across the US are some key factors driving the growth of the veterinary vaccines market in the region.
In September 2020, Applied DNA Sciences, Inc. and Evvivax, S.R.L., a spin-out of Takis Biotech focused on engineered veterinary immunotherapy and vaccines, are expected to initiate a veterinary clinical trial of one of the Company’s five LineaDNA vaccine candidates upon approval of the clinical plan by the US Department of Agriculture. The goal of the vaccine trial is to evaluate the vaccine candidate as a strategy for the prevention of SARS-CoV-2 (COVID-19) (a zoonotic disease) infections in companion felines of humans. This veterinary clinical trial will seek to understand the immune response in cats by utilizing a vaccination strategy of interest in people that could yield valuable data for both cats and humans.
Global Veterinary Vaccines Market Growth, by Region 2022-2028
Asia-Pacific to Exhibit Considerable Growth in the Global Veterinary Vaccines Market
Growing pet population, expansion of key players, and increasing productivity in emerging economies of Asia-Pacific such as India, China, and Japan are key factors driving the market growth in the region. India has 32 million pets, and the population is growing at a rate of more than 12.0% per year. Boehringer Ingelheim, announces that the swine vaccine Ingelvac PRRS MLV, produced by its veterinary vaccine manufacturing plant in the China Medical City in Taizhou, Jiangsu Province, is now officially supplied to the China market. Shifting imported vaccines to locally-produced vaccines will help significantly shorten the interval between the plant and animal farms. In the past, all swine vaccine products for the China market were imported and manufactured at the Boehringer Ingelheim’s plant in the US. Further, in April 2022, Ceva Santé Animale (“Ceva”), the French animal health company, formed “Ceva Bussan Animal Health K.K.”, a joint venture together with Mitsui & Co., Ltd. (Mitsui), to accelerate the expansion of the veterinary laboratory to Japan.
Market Players Outlook
The major companies serving the global veterinary vaccines market include Merck & Co. Inc., Zoetis Inc., Sanofi S.A., Boehringer Ingelheim International GmbH, and Ceva Sante Animale. The companies are focusing on product innovation, geographical expansion, mergers and acquisitions, and finding a new market or innovation in their core competency to expand individual market share.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global veterinary vaccines market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Veterinary Vaccines Market, By Product
4.1.1. Livestock Vaccines
4.1.2. Companion Animal Vaccines
4.1.3. Porcine Vaccines
4.1.4. Equine Vaccines
4.1.5. Poultry Vaccines
4.1.6. Aquaculture Vaccines
4.1.7. Others
4.2. Global Veterinary Vaccines Market, By Technology
4.2.1. Inactivated Vaccines
4.2.2. Live Attenuated Vaccines
4.2.3. Subunit Vaccines
4.2.4. Toxoid Vaccines
4.2.5. Recombinant Vaccines
4.2.6. DNA Vaccines
4.2.7. Conjugate Vaccines
4.3. Global Veterinary Vaccines Market, By Diseases
4.3.1. Poultry Diseases
4.3.2. Companion Animal Diseases
4.3.3. Livestock Diseases
4.3.4. Aquaculture Diseases
4.3.5. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Anicor Labor GmbH
6.2. Arko Laboratories, Inc.
6.3. Biovac
6.4. Boehringer Ingelheim GmbH
6.5. Ceva Sante Animale
6.6. Colorado Serum Co.
6.7. Hygieia Biological Laboratories
6.8. Merck & Co. Inc.
6.9. Merial
6.10. Nexvet
6.11. Pfizer Inc.
6.12. PHL Associates, Inc.
6.13. Romvac
6.14. Sanofi SA
6.15. Vaxxinova
6.16. Zoetis Inc.
1. GLOBAL VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
2. GLOBAL LIVESTOCK VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL COMPANION ANIMAL VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL PORCINE ANIMAL VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL EQUINE ANIMAL VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL POULTRY ANIMAL VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL AQUACULTURE ANIMAL VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OTHER ANIMAL VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
10. GLOBAL INACTIVATED VACCINES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL LIVE ATTENUATED VACCINES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL SUBUNIT VACCINES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL TOXOID VACCINES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL RECOMBINANT VACCINES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL DNA VACCINES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL CONJUGATE VACCINES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY DISEASES, 2021-2028 ($ MILLION)
18. GLOBAL VETERINARY VACCINES FOR POULTRY DISEASES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
19. GLOBAL VETERINARY VACCINES FOR COMPANION ANIMAL DISEASES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20. GLOBAL VETERINARY VACCINES FOR LIVESTOCK DISEASES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21. GLOBAL VETERINARY VACCINES FOR AQUACULTURE DISEASES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
22. GLOBAL VETERINARY VACCINES FOR OTHER DISEASES MARKET RESEARCH, AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
23. NORTH AMERICAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. NORTH AMERICAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
25. NORTH AMERICAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
26. NORTH AMERICAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY DISEASES, 2021-2028 ($ MILLION)
27. EUROPEAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
28. EUROPEAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
29. EUROPEAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
30. EUROPEAN VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY DISEASES, 2021-2028 ($ MILLION)
31. ASIA-PACIFIC VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
32. ASIA-PACIFIC VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
33. ASIA-PACIFIC VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
34. ASIA-PACIFIC VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY DISEASES, 2021-2028 ($ MILLION)
35. REST OF THE WORLD VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
36. REST OF THE WORLD VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
37. REST OF THE WORLD VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
38. REST OF THE WORLD VETERINARY VACCINES MARKET RESEARCH AND ANALYSIS BY DISEASES, 2021-2028 ($ MILLION)
1. GLOBAL VETERINARY VACCINES MARKET SHARE BY PRODUCT, 2020 VS 2027(%)
2. GLOBAL VETERINARY VACCINES MARKET SHARE BY TECHNOLOGY, 2020 VS 2027(%)
3. GLOBAL VETERINARY VACCINES MARKET SHARE BY DISEASES, 2020 VS 2027(%)
4. GLOBAL VETERINARY VACCINES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027(%)
5. GLOBAL LIVESTOCK VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
6. GLOBAL COMPANION ANIMAL VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
7. GLOBAL PORCINE VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
8. GLOBAL EQUINE VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
9. GLOBAL POULTRY VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
10. GLOBAL AQUACULTURE VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
11. GLOBAL OTHER VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
12. GLOBAL INACTIVATED VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
13. GLOBAL LIVE ATTENUATED VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
14. GLOBAL INACTIVATED VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
15. GLOBAL SUBUNIT VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
16. GLOBAL TOXOID VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
17. GLOBAL RECOMBINANT VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
18. GLOBAL DNA VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
19. GLOBAL CONJUGATE VACCINES MARKET SHARE BY REGION, 2020 VS 2027(%)
20. GLOBAL VETERINARY VACCINES FOR POULTRY DISEASES MARKET SHARE BY REGION, 2020 VS 2027(%)
21. GLOBAL VETERINARY VACCINES FOR COMPANION ANIMAL DISEASES MARKET SHARE BY REGION, 2020 VS 2027(%)
22. GLOBAL VETERINARY VACCINES FOR COMPANION ANIMAL DISEASES MARKET SHARE BY REGION, 2020 VS 2027(%)
23. GLOBAL VETERINARY VACCINES FOR LIVESTOCK ANIMAL DISEASES MARKET SHARE BY REGION, 2020 VS 2027(%)
24. GLOBAL VETERINARY VACCINES FOR AQUACULTURE ANIMAL DISEASES MARKET SHARE BY REGION, 2020 VS 2027(%)
25. GLOBAL VETERINARY VACCINES FOR OTHER ANIMAL DISEASES MARKET SHARE BY REGION, 2020 VS 2027(%)
26. US VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
27. CANADA VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
28. UK VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
29. FRANCE VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
30. GERMANY VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
31. ITALY VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
32. SPAIN VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
33. REST OF EUROPE VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
34. INDIA VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
35. CHINA VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
36. JAPAN VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
37. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
38. REST OF ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
39. REST OF THE WORLD VETERINARY VACCINES MARKET SIZE, 2021-2028 ($ MILLION)
